Fexofenadine in higher doses in chronic spontaneous urticaria.
作者信息
Godse Kiran V, Nadkarni Nitin J, Jani Gaurang, Ghate Sunil
机构信息
Department of Skin, Rajawadi Hospital, Ghatkopar, Mumbai, India.
出版信息
Indian Dermatol Online J. 2010 Jul;1(1):45-6. doi: 10.4103/2229-5178.73262.
Abstract
摘要
相似文献
1
Fexofenadine in higher doses in chronic spontaneous urticaria.
Indian Dermatol Online J. 2010 Jul;1(1):45-6. doi: 10.4103/2229-5178.73262.
2
Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria.
Ann Allergy Asthma Immunol. 2000 May;84(5):517-22. doi: 10.1016/S1081-1206(10)62515-X.
3
A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria.
J Allergy Clin Immunol. 1999 Nov;104(5):1071-8. doi: 10.1016/s0091-6749(99)70091-6.
4
[Chronic idiopathic urticaria: effectiveness of fexofenadine. A double-blind, placebo controlled study with 21 patients].
Praxis (Bern 1994). 2002 Apr 10;91(15):637-43. doi: 10.1024/0369-8394.91.15.637.
5
Review of fexofenadine in the treatment of chronic idiopathic urticaria.
Int J Dermatol. 2002 Oct;41(10):701-6. doi: 10.1046/j.1365-4362.2002.01599.x.
6
Multicenter study of the efficacy and safety of fexofenadine 60 mg. twice daily in 108 Thai patients with chronic idiopathic urticaria.
J Med Assoc Thai. 2001 Feb;84(2):153-9.
7
Fexofenadine: a review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria.
Drugs. 2000 Feb;59(2):301-21. doi: 10.2165/00003495-200059020-00020.
8
Fexofenadine: new preparation. Terfenadine, without cardiotoxicity.
Prescrire Int. 1999 Feb;8(39):11-3.
9
Effect of 60 mg twice-daily fexofenadine HCl on quality of life, work and classroom productivity, and regular activity in patients with chronic idiopathic urticaria.
J Am Acad Dermatol. 2000 Jul;43(1 Pt 1):24-30. doi: 10.1067/mjd.2000.104680.
10
Comparative efficacy of cetirizine and fexofenadine in the treatment of chronic idiopathic urticaria.
J Dermatolog Treat. 2004 Jan;15(1):55-7. doi: 10.1080/09546630310013450.
引用本文的文献
1
Advances in clinical application of H antihistamines in the treatment of skin diseases.
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024 Feb 28;49(2):182-189. doi: 10.11817/j.issn.1672-7347.2024.230452.
2
Efficacy and Safety of Up-dosed Second-generation Antihistamines in Uncontrolled Chronic Spontaneous Urticaria: A Review.
J Clin Aesthet Dermatol. 2023 Mar;16(3):44-50.
3
Clinical Characteristics of Patients with Chronic Urticaria and Adherence to Management Guidelines by Postgraduate Students in Dermatology: A Retrospective Single Center Study.
Indian J Dermatol. 2021 Nov-Dec;66(6):705. doi: 10.4103/ijd.ijd_446_21.
4
A Comparative, Three-Arm, Randomized Clinical Trial to Evaluate the Effectiveness and Tolerability of Bilastine vs Fexofenadine vs Levocetirizine at the Standard Dose and Bilastine vs Fexofenadine at Higher Than the Standard Dose (Up-Dosing) vs Levocetirizine and Hydroxyzine (in Combination) in Patients with Chronic Spontaneous Urticaria.
Clin Cosmet Investig Dermatol. 2022 Feb 18;15:261-270. doi: 10.2147/CCID.S350122. eCollection 2022.
5
Updosing of Nonsedating Anti-histamines in Recalcitrant Chronic Urticaria.
Indian J Dermatol. 2016 May-Jun;61(3):273-8. doi: 10.4103/0019-5154.182406.
6
Up-dosing of non-sedating antihistamines in chronic urticaria: Need for well-designed clinical trials in India.
Perspect Clin Res. 2014 Apr;5(2):88-90. doi: 10.4103/2229-3485.128029.
7
Consensus statement on the management of urticaria.
Indian J Dermatol. 2011 Sep-Oct;56(5):485-9. doi: 10.4103/0019-5154.87119.
8
H1-antihistamine up-dosing in chronic spontaneous urticaria: patients' perspective of effectiveness and side effects--a retrospective survey study.
PLoS One. 2011;6(9):e23931. doi: 10.1371/journal.pone.0023931. Epub 2011 Sep 1.
本文引用的文献
1
Updosing of antihistamines to improve control of chronic urticaria.
Indian J Dermatol Venereol Leprol. 2010 Jan-Feb;76(1):61-2. doi: 10.4103/0378-6323.58684.
2
EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria.
Allergy. 2009 Oct;64(10):1427-1443. doi: 10.1111/j.1398-9995.2009.02178.x.
3
EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria.
Allergy. 2009 Oct;64(10):1417-1426. doi: 10.1111/j.1398-9995.2009.02179.x.
4
Fexofenadine: biochemical, pharmacokinetic and pharmacodynamic properties and its unique role in allergic disorders.
Expert Opin Drug Metab Toxicol. 2009 Jul;5(7):813-22. doi: 10.1517/17425250903044967.
5
An evaluation of the effects of high-dose fexofenadine on the central nervous system: a double-blind, placebo-controlled study in healthy volunteers.
Clin Exp Allergy. 2002 Jan;32(1):133-9. doi: 10.1046/j.0022-0477.2001.01245.x.
6
Cardiovascular safety of fexofenadine HCl.
Clin Exp Allergy. 1999 Jul;29 Suppl 3:212-6. doi: 10.1046/j.1365-2222.1999.0290s3212.x.
7
Cardiovascular safety of fexofenadine HCl.
Am J Cardiol. 1999 May 15;83(10):1451-4. doi: 10.1016/s0002-9149(99)00124-1.
Zotero 插件